Neuvivo Funding & Investors
Neuvivo is a private, late-clinical stage biopharmaceutical company committed to creating and delivering advanced treatments for ALS and other neurodegenerative diseases.
neuvivo.comTotal Amount Raised: $11,000,000
Neuvivo Funding Rounds
Series Unknown
$11,000,000
Series Unknown Investors
Primestreet Group
Funding info provided by Diffbot.